Studies on ocular neovascularization by DNA microarray and RNA interference
DNA微阵列和RNA干扰对眼部新生血管形成的研究
基本信息
- 批准号:16390496
- 负责人:
- 金额:$ 8.96万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2004
- 资助国家:日本
- 起止时间:2004 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Retinal neovascularization in mice retina was produced by the method of Smith et al. The sensory retina was obtained from the model and mRNA expression changes were analyzed by Affimetrix Gene Chip MGU74 AV2. A total of 129 genes were found to be up- or down-regulated by more than twice or half of the control values in the model at P15. Among the up-regulated genes, we paid special attention to βB2-crystallin. βB2-crystallin and a-actin immunoreactivities were detected in glial cells that surrounded neovascular tufts. Short interfering RNA specific to βB2-crystallin were given to the model mice and ocular neovascularization was inhibited by the treatment. mRNA and protein expression were also inhibited by the treatment. βB2-crystallin immunoreactivities were detected in surgically obtained human tissues obtained by vitreous surgery. βB2-crystallin gene was transfected to HEK293 cells and cellular function was analyzed. In transfected cells, elongation of cellular process was observed and βB2-crystallin and a-actin were found to be co-localized underneath the cellular membrane. Our results showed that βB2-crystallin plays an important role in ocular (retinal) neovascularization.
采用Smith等的方法建立小鼠视网膜新生血管模型,取感觉视网膜,应用Affiliation Gene Chip MGU 74 AV 2分析其mRNA表达变化。共发现129个基因在P15时上调或下调超过模型中对照值的两倍或一半。在上调表达的基因中,我们特别关注了βB2-晶状体蛋白。βB2-晶体蛋白和α-肌动蛋白免疫反应在新生血管丛周围的胶质细胞中检测到。对模型小鼠给予βB2-晶状体蛋白特异性的短干扰RNA,治疗可抑制眼部新生血管的形成。mRNA和蛋白质表达也受到处理的抑制。在玻璃体手术获得的手术获得的人体组织中检测到βB2-晶状体蛋白免疫反应性。将βB2-晶状体蛋白基因转染HEK 293细胞,分析细胞功能。在转染的细胞中,观察到细胞突起的延长,并且发现βB2-晶体蛋白和α-肌动蛋白共定位于细胞膜下。我们的研究结果表明,βB2-晶状体蛋白在眼(视网膜)新生血管中起重要作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YOSHIMURA Nagahisa其他文献
YOSHIMURA Nagahisa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YOSHIMURA Nagahisa', 18)}}的其他基金
Development of the Method to Predict Efficacy of Anti-Vascular Endothelial Growth Factor Therapy for Exudative Age-Related Macular Degeneration Using Nuclear Magnetic Resonance
开发利用核磁共振预测抗血管内皮生长因子治疗渗出性年龄相关性黄斑变性疗效的方法
- 批准号:
26670753 - 财政年份:2014
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Development of neuroprotective treatment for incurable ocular diseases
开发针对无法治愈的眼部疾病的神经保护治疗方法
- 批准号:
24249082 - 财政年份:2012
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Personalized medicine for age-related macular degeneration
年龄相关性黄斑变性的个体化医疗
- 批准号:
21249084 - 财政年份:2009
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Investigation of the mechanism of age-related macular degeneration in Japanese patients through genomic analysis and stem cell biology
通过基因组分析和干细胞生物学研究日本患者年龄相关性黄斑变性的机制
- 批准号:
19390442 - 财政年份:2007
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
DNA microarray analysis of the gene expression changes in retinal neuronal cell death.
DNA微阵列分析视网膜神经细胞死亡中基因表达的变化。
- 批准号:
13470364 - 财政年份:2001
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
MOLECULAR MECHIANISM OF RETINAL GANGLION CELL APOTPTOSIS ANDEXPERIMENTAL GENE THERAPRYTO PREVENT THE CELL DEATH
视网膜神经节细胞凋亡的分子机制及预防细胞死亡的实验基因治疗
- 批准号:
10470361 - 财政年份:1998
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
An equipment for ocular hyperthermia experimental treatment of ocular tumors
眼部肿瘤实验性眼部热疗治疗设备
- 批准号:
02557067 - 财政年份:1989
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Developmental Scientific Research (B)
相似海外基金
Evaluating equitable access to diabetic retinopathy screening using social value judgement informed distributional cost-effectiveness analyses (Oppression framework informed equity cost-effectiveness analysis of diabetic retinopathy screening)
使用社会价值判断知情的分配成本效益分析评估糖尿病视网膜病变筛查的公平性(压迫框架知情的糖尿病视网膜病变筛查公平成本效益分析)
- 批准号:
495212 - 财政年份:2023
- 资助金额:
$ 8.96万 - 项目类别:
Subclass analysis of IL-17A and osteopontin-producing T cells involved in the development of diabetic retinopathy
IL-17A 和骨桥蛋白生成 T 细胞参与糖尿病视网膜病变发展的亚类分析
- 批准号:
23K09036 - 财政年份:2023
- 资助金额:
$ 8.96万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
OCTA Precursors of Vision-Threatening Complications of Diabetic Retinopathy
OCTA 糖尿病视网膜病变视力威胁并发症的前兆
- 批准号:
10718643 - 财政年份:2023
- 资助金额:
$ 8.96万 - 项目类别:
The Genetic Architecture of Diabetic Retinopathy
糖尿病视网膜病变的遗传结构
- 批准号:
10605816 - 财政年份:2023
- 资助金额:
$ 8.96万 - 项目类别:
Brain-gut-retina axis in diabetic retinopathy
糖尿病视网膜病变中的脑-肠-视网膜轴
- 批准号:
10595142 - 财政年份:2023
- 资助金额:
$ 8.96万 - 项目类别:
Correction of diabetic retinopathy by mitochondrial transfer
通过线粒体转移纠正糖尿病视网膜病变
- 批准号:
10658455 - 财政年份:2023
- 资助金额:
$ 8.96万 - 项目类别:
Characterizing the prevalence and nature of facial recognition deficits in non-proliferative diabetic retinopathy
描述非增殖性糖尿病视网膜病变中面部识别缺陷的患病率和性质
- 批准号:
10667781 - 财政年份:2023
- 资助金额:
$ 8.96万 - 项目类别:
Novel ultrahigh speed swept source OCT angiography methods in diabetic retinopathy
糖尿病视网膜病变的新型超高速扫源 OCT 血管造影方法
- 批准号:
10656644 - 财政年份:2023
- 资助金额:
$ 8.96万 - 项目类别:
Pro/renin receptor-mediated signaling in pathogenesis of diabetic retinopathy
糖尿病视网膜病变发病机制中Pro/肾素受体介导的信号传导
- 批准号:
10718033 - 财政年份:2023
- 资助金额:
$ 8.96万 - 项目类别:














{{item.name}}会员




